Our Services
Medical Information
Helpful Resources
Published on: 4/5/2026
In early pregnancy, Lexapro side effects like nausea, fatigue, headaches, and sleep changes can overlap with normal symptoms, and many people feel more stable by the second trimester as side effects often ease. In the third trimester, most continue to tolerate it, but babies may have brief neonatal adaptation symptoms after birth and there is a very small increase in PPHN risk, while the overall risk of major birth defects with SSRIs remains low.
Do not stop Lexapro without medical guidance, since continued treatment often outweighs risks and supports mental health; see below for individualized pros and cons, trimester-specific side effect tips, breastfeeding considerations, monitoring plans, and the red flags that mean you should call a doctor.
If you're pregnant and taking Lexapro (escitalopram), it's normal to have questions. You may be wondering how Lexapro side effects could affect you or your baby, and what changes to expect as your pregnancy progresses.
Lexapro is a commonly prescribed selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety. For many people, staying on antidepressant treatment during pregnancy is important for their mental health and overall well-being. Untreated depression or anxiety can also pose risks during pregnancy, including poor nutrition, sleep problems, and difficulty with prenatal care.
This guide walks you through what to expect from Lexapro side effects during each trimester, based on credible medical evidence, and how to manage them safely.
The first trimester is a critical time for fetal development. It's also when pregnancy symptoms and medication side effects can overlap.
Many of the typical Lexapro side effects may feel more noticeable early on:
Because nausea and fatigue are also common in early pregnancy, it can be hard to tell what's causing what.
Large studies of SSRIs, including escitalopram, suggest that the overall risk of major birth defects is low. Some research has examined possible associations between SSRIs and certain heart defects, but the absolute risk remains small.
For most patients:
Do not stop or change your dose without medical guidance.
The second trimester is often described as the most physically comfortable part of pregnancy. Many early pregnancy symptoms ease, and medication side effects may stabilize.
By this stage:
However, some Lexapro side effects can continue, such as:
In rare cases, SSRIs may contribute to:
Your prenatal care provider will monitor your blood pressure and weight regularly, which helps detect any concerns early.
This trimester is often when patients feel more emotionally stable if treatment is working. Staying consistent with medication can:
Untreated depression during pregnancy has been associated with preterm birth, low birth weight, and increased stress hormones. That's why ongoing treatment can be protective.
The third trimester brings new physical demands and considerations.
Most people tolerate Lexapro well through the third trimester. However, some potential concerns include:
Babies exposed to SSRIs late in pregnancy may experience temporary symptoms after birth, such as:
These symptoms are typically:
Severe complications are rare.
Some studies suggest a small increased risk of PPHN with SSRI use in late pregnancy. However:
Your obstetric and pediatric teams will monitor your baby after birth.
In the past, some providers recommended tapering SSRIs late in pregnancy. Current evidence does not routinely support this approach.
Stopping Lexapro late in pregnancy may:
Any decision about adjusting your medication should be individualized and made with your prescribing physician and obstetric provider.
If you remain on Lexapro during pregnancy, your care team may:
If you're experiencing unusual symptoms and want to better understand whether they could be related to your antidepressant use, you can use a free symptom checker for currently on antidepressants to help identify which symptoms may need medical attention.
While most Lexapro side effects are mild, seek urgent medical care if you experience:
Any potentially life-threatening symptom requires immediate medical evaluation.
Lexapro does pass into breast milk in small amounts. However:
Discuss breastfeeding plans with your healthcare provider before delivery so you can make an informed choice.
It's important not to view medication decisions through fear alone. Untreated depression and anxiety during pregnancy can:
For many patients, staying on Lexapro provides emotional stability that benefits both parent and baby.
Most Lexapro side effects during pregnancy are manageable and similar to those experienced outside of pregnancy. Serious complications are uncommon, and for many individuals, the benefits of continued treatment outweigh the risks.
Every pregnancy is unique. Medication decisions should always be personalized based on:
If you are pregnant and taking Lexapro—or considering stopping it—speak to your doctor before making any changes. Never discontinue antidepressants abruptly without medical supervision.
And if you notice new or concerning symptoms, especially anything severe or potentially life-threatening, seek medical care immediately.
Your mental health matters. With the right support and monitoring, many people continue Lexapro safely throughout pregnancy and go on to have healthy pregnancies and healthy babies.
(References)
* Biffi V, et al. First-trimester exposure to escitalopram and risk of major congenital malformations: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021 Apr;303(4):857-867. doi: 10.1007/s00404-020-05886-0. PMID: 33269666.
* Klinger G, et al. Neonatal adaptation syndrome after intrauterine exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis. Front Pediatr. 2023 Feb 15;11:1115598. doi: 10.3389/fped.2023.1115598. PMID: 36873966; PMCID: PMC9975765.
* Fougner M, et al. Fetal and Neonatal Outcomes After Exposure to Escitalopram During Pregnancy. J Clin Psychopharmacol. 2021 May-Jun;41(3):233-242. doi: 10.1097/JCP.0000000000001389. PMID: 33857022.
* Bérard A, et al. Antidepressant use during pregnancy and the risk of persistent pulmonary hypertension of the newborn: a systematic review and meta-analysis. BJOG. 2022 Apr;129(5):715-726. doi: 10.1111/1471-0528.17066. Epub 2022 Feb 16. PMID: 35171965.
* Kaplan Y, et al. Prenatal Antidepressant Exposure and Neurodevelopmental Outcomes: A Systematic Review. J Clin Psychopharmacol. 2022 Mar-Apr 01;42(2):167-179. doi: 10.1097/JCP.0000000000001509. PMID: 35149303.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.